Full Text View
Tabular View
No Study Results Posted
Related Studies
TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma
This study has been terminated.
( Drug company withdrawal of support for investigational agent in this indication. )
Study NCT00074334   Information provided by Pediatric Brain Tumor Consortium
First Received: December 10, 2003   Last Updated: October 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Nervous System Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Site
Nervous System Diseases
Interventions listed in this trial
TGFa-PE38 immunotoxin
conventional surgery
Additional drug interventions recognized in this trial
Immunotoxins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services